Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ziprasidone Open Extension in Schizophrenia
NCT00174447Phase 3Completed
- Sponsor
- Viatris
- Start
- Oct 2001
- Primary completion
- Oct 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of ziprasidone in schizophrenia, sponsored by Viatris. Primary endpoints: Clinical Global Impression - Improvement, Change From Baseline in CGI-I and 2 more. Started Oct 2001; status: completed.
02
Drugs
ziprasidone
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT00174447.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00174447.